Concepedia

Mark P. Labrecque

MP

Statistics

Publications

16

Citations

1K

H-Index

13

Active since

2010

Affiliations

University of Washington(Current)

Fred Hutch Cancer Center

Simon Fraser University

Michigan Medicine

University of British Columbia

Mark P. Labrecque is an author at University of Washington specializing in medicine, oncology, and prostate cancer.

ORCID

Publications per year

2010–2023

16

Publications

16

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown et al. · Journal of Clinical Investigation · 2019 · 468 citations · Full text

, , +17

Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer

Diana C. DeLucia, Thomas M. Cardillo, Lisa S. Ang et al. · Clinical Cancer Research · 2020 · 86 citations · Full text

, , +17

BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program

Dae‐Hwan Kim, Duanchen Sun, William K. Storck et al. · Clinical Cancer Research · 2021 · 71 citations · Full text

, , +17

Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts

Hung‐Ming Lam, Holly M. Nguyen, Mark P. Labrecque et al. · European Urology · 2019 · 63 citations · Full text

, , +17

RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer

Mark P. Labrecque, Lisha G. Brown, Ilsa M. Coleman et al. · Cancer Research · 2021 · 53 citations · Full text

, , +16

1–5 of 16